Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.000
+0.170 (4.44%)
Jan 28, 2026, 4:00 PM EST - Market closed
Camp4 Therapeutics Revenue
Camp4 Therapeutics had revenue of $795.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $3.80M. In the year 2024, Camp4 Therapeutics had annual revenue of $652.00K with 86.29% growth.
Revenue (ttm)
$3.80M
Revenue Growth
+86.29%
P/S Ratio
22.33
Revenue / Employee
$69,127
Employees
55
Market Cap
207.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAMP News
- 12 days ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 22 days ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 6 weeks ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire